1. Negrete, J. C. (1983) Psychiatric effects of cannabis use, in Cannabis and Health Hazards ( O'Brien Fehr, K. and Kalant, H., eds.), Addiction Research Foundation, Toronto, Ontario, pp. 577–601.
2. Mueser, K. T., Yarnold, R. R., Levinson, D. F., Mueser, K. T., Yarnold, P. R., Levinson, D. F., Singh, H., Bel-lack, A. S., Kee, K., Morrison, R. L., and Yadalam, K. G. (1990) Prevalence of substance abuse in schizophrenia: demographic and clinical correlates. Schizophr. Bull. 16, 31–42.
3. Bland, R. C., Newman, S. L. and Orn, H. (1987) Schizophrenia: lifetime co-morbidity in a community sample. Acta Psychiatr. Scand. 75, 383–391.
4. Verdoux, H., Mury, M., Besancon, G., Verdoux, H., Mury, M., Besancon, G., and Bourgeois, M. (1996) Comparative study of substance dependence comorbidity in bipolar, schizophrenic and schizoaffective disorders. Encephale
22, 95–101.
5. Modestin, J., Nussbaumer, C., Angst, K., Modestin, J. Nussbaumer, C., Angst, K., Scheidegger, P., and Hell, D. (1997) Use of potentially abusive psychotropic substances in psychiatric inpatients. Eur. Arch. Psychiatry Clin. Neurosci. 247 (3), 146–153.